UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C. 20549
|
|
|
|
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act
of 1934
Date of
Report (Date of earliest event reported) March 17,
2017
|
|
Cross Country Healthcare, Inc.
(Exact
name of registrant as specified in its charter)
|
|
|
Delaware
|
0-33169
|
13-4066229
|
|
(State
or Other Jurisdiction
of
Incorporation)
|
(Commission
File
Number)
|
(I.R.S.
Employer
Identification
No.)
|
5201 Congress Avenue, Boca Raton, FL 33487
(Address
of Principal Executive Office) (Zip Code)
(561) 998-2232
(Registrant’s
telephone number, including area code)
Not Applicable
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
☐
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
☐
Soliciting material
pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
☐
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
☐
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
Item 8.01 Other
Information
On
March 17, 2017, Cross Country Healthcare, Inc. (the
“Company”) repaid in full its convertible senior notes
(the “Convertible Notes”). The Convertible Notes, with
an aggregate principal amount of $25,000,000, were convertible into
shares of the Company’s common stock, par value $0.0001 per
share (the “Common Stock”), at a conversion price of
$7.10 per share. In connection with the repayment, the Company
issued to the holders of the Convertible Notes an aggregate of
3,175,584 shares of Common Stock and cash in the aggregate amount
of $5,988,889, including all remaining interest payments through
the optional conversion date of June 30, 2017.
|
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf
by the undersigned, hereunto duly authorized.
|
|
|
CROSS COUNTRY HEALTHCARE, INC.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
/s/
William J. Burns
|
|
|
|
|
William J. Burns
|
|
Dated:
|
March 17, 2017
|
|
EVP, Chief Financial Officer
|